ExploreWatchlistsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Marketable securities, non-current

SANTEN PHARMACEUTICAL CO.,LTD. (4536)

Market cap
¥615.9B
P/E ratio
17.5x
Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 20258,515-40.33%
Mar 31, 202414,270-28.99%
Mar 31, 202320,097-6.05%
Mar 31, 202221,392-19.06%
Mar 31, 202126,429-3.44%
Mar 31, 202027,371+1.36%
Mar 31, 201927,003-20.16%
Mar 31, 201833,823+20.48%
Mar 31, 201728,074-34.69%
Mar 31, 201642,983+28.89%
Mar 31, 201533,349

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat